Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared a post on X:
“GI25 this is a COOL study.
FOLFOX-B:
- BOT
- BAL
- BEV
Immunotherapy alone may not work for those with active liver metastases. But in a refractory patient population, this is encouraging to see.
Need more ideas for patients with liver metastases.”
